Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 December 2024 | Story André Damons | Photo André Damons
Dr Innocensia Mangoato
Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. Here she is with her supervisor and mentor Prof Motlalepula Matsabisa, Director of the University of the Free State (UFS) Department of Pharmacology.

A lecturer and researcher from the University of the Free State (UFS) Department of Pharmacology hopes her research into the use of cannabis in reversing anticancer drug resistance is a step forward into treating various cancers especially in Southern Africa.

Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with the degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. She started her career as a research scientist in the area of African traditional medicines in 2018 and her research received both national and international recognition.

“It’s an amazing (feeling to graduate today). My PhD journey was smooth and beautiful and with mentorship of Prof (Motlalepula) Matsabisa, who groomed me well, I did not shed a tear,” said Dr Mangoato. Dr Gudrun S Ulrich-Merzenich from the University of Bonn in Germany, was her co-supervisor with Prof Matsabisa.

According to the graduation programme, Dr Mangoato, Lecturer and Researcher in the UFS Department of Pharmacology, with her thesis titled Investigating the anticancer and possible resistant reversal effects of cannabis sativa l. extracts in cervical cancer cell lines and modulation of ABC transporters comprehensively explored the therapeutic potential of Cannabis sativa L. in overcoming drug resistance in cervical cancer using in vitro and network pharmacology approaches.

A step forward for treating various cancers

The research looked at the chemical fingerprints and pharmacological targets of C. sativa L. extracts, highlighting its antiproliferative properties against normal non-cancerous cells, cervical cancer cells and the cisplatin-resistant cervical cancer cells. Through PCR analysis, distinct gene expression profiles were identified, revealing the potential effects of combination treatments to counteract cisplatin resistance by downregulating genes associated with drug transporters and crucial signalling pathways. This work provides valuable insights into innovative therapeutic strategies for improving cervical cancer treatment, highlighting new avenues for overcoming resistance and enhancing treatment efficacy though the possible use of plant extracts.

“I hope my research takes a step forward in treating various cancers – especially gynaecology cancers in the Southern Hemisphere in Africa. Hopefully the research can later transcend into clinical trials and hopefully influence more policymakers. We also hope to further develop cannabis to be used as an adjuvant therapy for those drugs that are failing to treat cancer,” says Dr Mangoato, who was the recipient of the Women in Science Master’s Student in 2018.

Her graduation was also a proud moment for Prof Matsabisa, an expert in traditional African medicine, who was like a father to her during her studies. “Prof identified me from my honours degree and walked this journey with me. He has been a great mentor, a father and an amazing supervisor.”

Dr Mangoato says she will for now focus on research only and helping and monitoring upcoming researchers, especially female researchers as there is a scarcity of them her field. 

News Archive

Curtains fall on Darwin lecture series
2010-02-03

The University of the Free State (UFS), in collaboration with the Central University of Technology and the National Museum in Bloemfontein, will host the final lecture of the Charles Darwin lecture series entitled "The story of life and survival" as part of the 200-years celebration of Charles Darwin’s birthday on Thursday, 11 February 2010.

The lecture titled Trends in evolution and their bearing on the future of humankind will be presented by Prof. Bruce Rubidge and Prof. Terence McCarthy from the University of the Witwatersrand and co-authors of the book The Story of Earth and Life.

Last year, when the year-long lecture series started, several lectures were presented by academics from various departments at the UFS.
Prof. Marian Tredoux and Mr Johan Loock from the Department of Geology presented lectures on The origin of our solar system and The geological evolution of our planet: the first billion years, respectively.

"Transitions and extinctions" was the topic of another lecture presented by Dr Jennifer Botha-Brink, a paleontologist at the National Museum and affiliated to the Department of Zoology and Entomology at the UFS. She discussed the causes of mass extinctions and their effects on the world's organisms.

The Department of Genetics also made their contribution to this lecture series in the form of two lectures on the genetic foundation of evolution presented by the Head of the Department, Prof. Johan Spies and Prof. Paul Grobler, an Associate Professor in the Department.

Next followed lectures on the evolution of the information and communication technology that were presented by the Departments of Communication Science, Chemistry, Physics, and Computer Science and Informatics, which focused on communication in a manufacturing environment, the knowledge explosion and the broadband universe.

This final lecture of the series will be presented in the CR Swart Auditorium on the UFS Main Campus at 18:00. Limited seats are available and bookings can be made by contacting Ms Isabel Human at humanci@ufs.ac.za or 051 401 2427 before or on Monday, 8 February 2010.

Media Release:
Mangaliso Radebe
Assistant Director: Media Liaison
Tel: 051 401 2828
Cell: 078 460 3320
E-mail: radebemt@ufs.ac.za  
2 February 2010

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept